Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults (18 years or older)
- People who have received a drug called abemaciclib together with hormone therapy as part of their breast cancer treatment after surgery (known as adjuvant therapy)
- People diagnosed with a localised breast cancer that is hormone receptor positive (HR+) and HER2 non-amplified (a specific tumour type based on lab testing), where the cancer had spread to nearby lymph nodes under the arm on the same side as the tumour, meeting at least one of the following conditions:
- 4 or more lymph nodes affected, OR
- 1 to 3 lymph nodes affected AND the tumour was either classified as grade 3 (a higher-grade, faster-growing cancer) or measured 5 cm or larger in size
Who may not be able to join:
- People who are under a legal protection order, such as guardianship or trusteeship
- People who do not wish to take part in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0298223396
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
the average dose of abemaciclib received over 6 months.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.